References:
1. Muller, G. W., Chen, R., Huang, S. Y., Corral, L. G., Wong, L. M., Patterson, R. T., Chen, Y., Kaplan, G. and Stirling, D. I. (1999) Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett. 9, 1625-163
2. Moutouh-de Parseval, L. A., Verhelle, D., Glezer, E., Jensen-Pergakes, K., Ferguson, G. D., Corral, L. G., Morris, C. L., Muller, G., Brady, H. and Chan, K. (2008) Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells. J Clin Invest. 118, 248-258
3. Li, Z., Qiu, Y., Personett, D., Huang, P., Edenfield, B., Katz, J., Babusis, D., Tang, Y., Shirely, M. A., Moghaddam, M. F., Copland, J. A. and Tun, H. W. (2013) Pomalidomide shows significant therapeutic activity against CNS lymphoma with a major impact on the tumor microenvironment in murine models. PLoS One. 8, e71754
|